-
1
المؤلفون: Leticia Kawano-Dourado, Thomas Agoritsas, John Adabie Appiah, Minhua Huang, Reed A C Siemieniuk, Srinivas Murthy, Seema Kanda, Maria Asuncion A. Silvestre, Gordon Guyatt, Long Ge, Bram Rochwerg, Yee Sin Leo, Begüm Ergan, Dena Zeraatkar, Per Olav Vandvik, Arthur Kwizera, Linan Zeng, Heike Geduld, Hela Manai, Francois Lamontagne, Arnav Agarwal, Zhikang Ye, Jessica J Bartoszko, Hayley B. Gershengorn, Linda Kurian, Nida Qadir, Romina Brignardello-Petersen
المصدر: BMJ (Clinical Research Edition), Vol. 370 (2020) P. m2924
BMJمصطلحات موضوعية: medicine.medical_specialty, Respiration, Artificial/statistics & numerical data, Time Factors, Coronavirus disease 2019 (COVID-19), Adenosine Monophosphate/analogs & derivatives/therapeutic use, Network Meta-Analysis, Pneumonia, Viral, MEDLINE, Antiviral Agents, Severity of Illness Index, Pneumonia, Viral/diagnosis/mortality/therapy/virology, 03 medical and health sciences, Betacoronavirus, 0302 clinical medicine, Severity of illness, medicine, Effective treatment, Humans, In patient, 030212 general & internal medicine, Intensive care medicine, Coronavirus Infections/diagnosis/drug therapy/mortality/therapy/virology, Pandemics, 030304 developmental biology, Randomized Controlled Trials as Topic, ddc:616, Antiviral Agents/therapeutic use, 0303 health sciences, Betacoronavirus/isolation & purification, Alanine, business.industry, SARS-CoV-2, COVID-19, General Medicine, Guideline, Length of Stay, Respiration, Artificial, Adenosine Monophosphate, COVID-19 Drug Treatment, Clinical Practice, Trustworthiness, Treatment Outcome, Length of Stay/statistics & numerical data, Guideline Adherence, business, Coronavirus Infections, Alanine/analogs & derivatives/therapeutic use
-
2
المؤلفون: Mi Ah Han, Farid Foroutan, Andrés Viteri-García, Gordon H Guyatt, Kimia Honarmand, Francois Lamontagne, Xiaorong Hou, Jessica J Bartoszko, Ariel Izcovich, Bonnie Lam, Arnav Agarwal, Assem M. Khamis, Maryam Ghadimi, Andrea Darzi, John Neary, Britta Tendal, Tari Turner, Srinivas Murthy, Sharhzad Motaghi, Quazi Ibrahim, Bo Fang, Diane Heels-Ansdell, Romina Brignardello-Petersen, Gabriel Rada, Reem A. Mustafa, Robin W.M. Vernooij, Anila Qasim, Maura Marcucci, Tahira Devji, Mark Loeb, Thomas Agoritsas, Signe Flottorp, Long Ge, Liangying Hou, Liang Yao, Bram Rochwerg, Behnam Sadeghirad, Qin Liu, Rachel Couban, Ying Wang, Dena Zeraatkar, Lehana Thabane, Irbaz Bin Riaz, Hector Pardo-Hernandez, Shelley McLeod, Carmen Fang, Elena Kum, Ashwini Sreekanta, Charlotte Switzer, George Tomlinson, Zhikang Ye, Lulu Sheng, Ellen Cusano, Juan Pablo Diaz Martinez, Reed A C Siemieniuk, Per Olav Vandvik, Derek K. Chu, Nigar Sekercioglu
المصدر: BMJ. British Medical Journal
BMJ (Clinical Research Edition), Vol. 370 (2020) P. m2980
BMJمصطلحات موضوعية: Glucocorticoids/therapeutic use, Centers for Disease Control and Prevention, U.S./statistics & numerical data, Databases, Factual, medicine.medical_treatment, viruses, Adenosine Monophosphate/analogs & derivatives/therapeutic use, Network Meta-Analysis, Severity of Illness Index, Pneumonia, Viral/diagnosis/mortality/therapy/virology, Lopinavir, China/epidemiology, Randomized Controlled Trials as Topic, ddc:616, Antiviral Agents/therapeutic use, Alanine, Evidence-Based Medicine, Absolute risk reduction, virus diseases, Betacoronavirus/isolation & purification/pathogenicity, Standard of Care, General Medicine, Databases, Factual/statistics & numerical data, United States/epidemiology, Drug Combinations, Treatment Outcome, Meta-analysis, Hydroxychloroquine/therapeutic use, Coronavirus Infections, Hydroxychloroquine, medicine.medical_specialty, China, Respiration, Artificial/statistics & numerical data, Ritonavir/therapeutic use, Pneumonia, Viral, MEDLINE, Evidence-Based Medicine/methods/statistics & numerical data, Placebo, Antiviral Agents, Betacoronavirus, Severity of illness, medicine, Humans, Coronavirus Infections/diagnosis/drug therapy/mortality/therapy/virology, Glucocorticoids, Pandemics, Lopinavir/therapeutic use, Mechanical ventilation, Ritonavir, business.industry, SARS-CoV-2, COVID-19, Evidence-based medicine, Respiration, Artificial, Adenosine Monophosphate, United States, COVID-19 Drug Treatment, Clinical trial, Emergency medicine, Centers for Disease Control and Prevention, U.S, business, Alanine/analogs & derivatives/therapeutic use
وصف الملف: application/pdf
-
3
المؤلفون: Carlos Guijarro, Farid Zand, Mohamed solyman Kabil, Sven Trelle, Birgitte Tholin, Belén Comeche, Johan Alexander Azañero Haro, Gonzalo Sierra Torres, Quarraisha Abdool Karim, Kari Tikkinen, Jean-michel Molina, Atousa Hakamifard, George M Varghese, Oscar Josue Ponce Ponte, Mazin Barry, Pilar Vizcarra, Niccolo Riccardi, Natalia Pérez-Macias, Aynaa AlSharidi, Nelson Lee, Alexandra Binnie, Firouzé BANI-SADR, Beatriz Díaz-Pollán, Aldo Pietro Maggioni, Ilkka Kalliala, Florian Desgranges, Anders Benjamin Kildal, Katerina Nezvalova-Henriksen, Corinne Merle, Andrés Martín Alcántara, Benjamin Gaborit, Daniel Lozano Martín, Antonio Ramos-Martinez, Miguel Villegas-Chiroque, Fredy Orlando Guevara Pulido, Ana Fernández-Cruz, Cormac McCarthy, Thesla Palanee-Phillips, Annalisa Marinosci, Abdullah Assiri, Florent Wallet, Juan Pablo Balbuena, Avik Ray, Francesc Puchades, Rajarao Mesipogu, Marjatta Sinisalo, Jonathan Sterne, Antonio Portolés, Heike Cappel-Porter, Jussi Mustonen, Jeremy Nel, BRUNO MOURVILLIER, María Consuelo Miranda Montoya, Chiara Fanciulli, L Marjukka Myllärniemi, Edinson Dante Meregildo Rodriguez, Alexy Inciarte, Mohamed Hassany, François Danion, Elena Muñez Rubio, Jean-Pierre QUENOT, Esperanza Merino de Lucas, Sheela Godbole, Luis Guillermo Barreto Rocchetti, Katerina Spasovska, William Connors, Kiana Shirani, Umang Agrawal, Srinivas Murthy, Bjorn Blomberg, Vasee Moorthy, Amith Balachandran, Antonio De Pablo Esteban, Mahnaz Amini, Dag Arne Lihaug Hoff, Zeinab Siami, Guillaume Martin-Blondel, Heng Gee Lee, Thrilok Chander Bingi, Vijay Krishnan, ANA BELEN RIVAS PATERNA, Eric D'Ortenzio, Samy Zaky, Carlos Arturo Alvarez-Moreno, Alonso Soto, VIKAS MARWAH, Marco Tulio Medina, Zaira R. Palacios-Baena, Jean-Sébastien Hulot, Miguel Angel Hueda Zavaleta, Felipe García, Francisco Fanjul
المساهمون: Hospices Civils de Lyon (HCL), INSERM UMR-S 606, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris, PRES Sorbonne Paris-Cité, and Université Paris Denis Diderot, Université Paris Diderot - Paris 7 (UPD7), Michel-Avella, Amandine, Pan, H., Peto, R., Henao-Restrepo, A. -M., Preziosi, M. -P., Sathiyamoorthy, V., Karim, Q. A., Alejandria, M. M., Garcia, C. H., Kieny, M. -P., Malekzadeh, R., Murthy, S., Srinath Reddy, K., Periago, M. R., Hanna, P. A., Ader, F., Al-Bader, A. M., Alhasawi, A., Allum, E., Alotaibi, A., Alvarez-Moreno, C. A., Appadoo, S., Asiri, A., Aukrust, P., Barratt-Due, A., Bellani, S., Branca, M., Cappel-Porter, H. B. C., Cerrato, N., Chow, T. S., Como, N., Eustace, J., Garcia, P. J., Godbole, S., Gotuzzo, E., Griskevicius, L., Hamra, R., Hassan, M., Hassany, M., Hutton, D., Irmansyah, I., Jancoriene, L., Kirwan, J., Kumar, S., Lennon, P., Lopardo, G., Lydon, P., Magrini, N., Maguire, T., Manevska, S., Manuel, O., Mcginty, S., Medina, M. T., Mesa Rubio, M. L., Miranda-Montoya, M. C., Nel, J., Nunes, E. P., Perola, M., Portoles, A., Rasmin, M. R., Raza, A., Rees, H., Reges, P. P. S., Rogers, C. A., Salami, K., Salvadori, M. I., Sinani, N., Sterne, J. A. C., Stevanovikj, M., Tacconelli, E., Tikkinen, K. A. O., Trelle, S., Zaid, H., Rottingen, J. -A., Swaminathan S., &, Luzzati, R, Di Bella, S, Doctoral Programme in Population Health, Doctoral Programme in Biomedicine, HUS Abdominal Center, Department of Surgery, Urologian yksikkö, South Carelia Social and Health care District Eksote, HUS Heart and Lung Center, Department of Medicine, Clinicum, Department of Obstetrics and Gynecology, HUS Gynecology and Obstetrics, UCL - SSS/IREC/LTAP - Louvain Centre for Toxicology and Applied Pharmacology, UCL - (SLuc) Service de médecine interne générale
المصدر: New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2021, 384 (6), pp.497-511. ⟨10.1056/NEJMoa2023184⟩
Pan, Hongchao; Peto, Richard; Henao-Restrepo, Ana-Maria; Preziosi, Marie-Pierre; Sathiyamoorthy, Vasee; Abdool Karim, Quarraisha; Alejandria, Marissa M; Hernández García, César; Kieny, Marie-Paule; Malekzadeh, Reza; Murthy, Srinivas; Reddy, K Srinath; Roses Periago, Mirta; Abi Hanna, Pierre; Ader, Florence; Al-Bader, Abdullah M; Alhasawi, Almonther; Allum, Emma; Alotaibi, Athari; Alvarez-Moreno, Carlos A; ... (2021). Repurposed Antiviral Drugs for Covid-19-Interim WHO Solidarity Trial Results. New England journal of medicine NEJM, 384(6), pp. 497-511. Massachusetts Medical Society MMS 10.1056/NEJMoa2023184 <http://dx.doi.org/10.1056/NEJMoa2023184>
The New England journal of medicine, Vol. 384, no.6, p. 497-511 (2021)
2020, ' Repurposed Antiviral Drugs for Covid-19-Interim WHO Solidarity Trial Results ', New England Journal of Medicine . https://doi.org/10.1056/NEJMoa2023184مصطلحات موضوعية: Male, Kaplan Meier method, Intention to Treat Analysi, MESH: Treatment Failure, MESH: Hydroxychloroquine, remdesivir, Rate ratio, MESH: Intention to Treat Analysis, MESH: Length of Stay, law.invention, Lopinavir/*therapeutic use, 0302 clinical medicine, middle aged, Medicine, Hospital Mortality, MESH: Respiration, Artificial, Antiviral Agents/administration & dosage/adverse effects/*therapeutic use, comparative study, beta1a interferon, MESH: Middle Aged, Alanine, Respiration, adult, clinical trial, General Medicine, 3. Good health, Intention to Treat Analysis, [SDV] Life Sciences [q-bio], aged, health care quality, priority journal, drug withdrawal, Artificial, Interferon, Drug Therapy, Combination, medicine.medical_specialty, Initiation of ventilation, Interferon beta-1a/*therapeutic use, World Health Organization, Antiviral Agents, Article, Duration of hospital stay, antiviral drugs, 03 medical and health sciences, Drug Therapy, death, Humans, MESH: Hospital Mortality, human, MESH: Kaplan-Meier Estimate, Aged, MESH: Humans, treatment duration, extracorporeal oxygenation, Hydroxychloroquine, Length of Stay, major clinical study, mortality, Respiration, Artificial, Adenosine Monophosphate/*analogs & derivatives/therapeutic use, multicenter study, Alanine/*analogs & derivatives/therapeutic use, MESH: Interferon beta-1a, randomized controlled trial, MESH: Female, antivirus agent, [SDV]Life Sciences [q-bio], MESH: Hospitalization, Kaplan-Meier Estimate, 030204 cardiovascular system & hematology, Lopinavir, Adenosine Monophosphate, COVID-19, Female, Hospitalization, Interferon beta-1a, Middle Aged, Treatment Failure, Randomized controlled trial, Interquartile range, law, MESH: COVID-19, MESH: Adenosine Monophosphate, 030212 general & internal medicine, antiviral drugs, Covid-19, MESH: Aged, Hydroxychloroquine/*therapeutic use, MESH: Lopinavir, Covid19, artificial ventilation, drug therapy, ritonavir, hospital patient, female, Combination, medicine.drug, MESH: Antiviral Agents, combination drug therapy, COVID-19/*drug therapy/mortality, Randomization, MESH: Alanine, drug repositioning, drug clearance, adenosine phosphate, coronavirus disease 2019, length of stay, Internal medicine, controlled study, Antiviral Agent, Intention-to-treat analysis, business.industry, MESH: Male, COVID-19 Drug Treatment, purl.org/pe-repo/ocde/ford#3.02.00 [https], MESH: Drug Therapy, Combination, 3121 General medicine, internal medicine and other clinical medicine, business
وصف الملف: application/pdf
-
4دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
5مورد إلكتروني
المصدر: The New England journal of medicine, 384 (6
مصطلحات الفهرس: Sciences bio-médicales et agricoles, Adenosine Monophosphate -- analogs & derivatives -- therapeutic use, Aged, Alanine -- analogs & derivatives -- therapeutic use, Antiviral Agents -- administration & dosage -- adverse effects -- therapeutic use, COVID-19 -- mortality, Drug Therapy, Combination, Female, Hospital Mortality, Hospitalization, Humans, Hydroxychloroquine -- therapeutic use, Intention to Treat Analysis, Interferon beta-1a -- therapeutic use, Kaplan-Meier Estimate, Length of Stay, Lopinavir -- therapeutic use, Male, Middle Aged, Respiration, Artificial, Treatment Failure, COVID-19 Drug Treatment, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article
URL:
https://dipot.ulb.ac.be/dspace/bitstream/2013/352869/1/PMC7727327.pdf http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/352869 http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL